Tectonic Therapeutic, Inc.
TECX
$32.68
-$0.63-1.89%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -74.15M | -67.30M | -65.98M | -58.67M | -57.98M |
| Total Depreciation and Amortization | 1.38M | 1.55M | 1.63M | 1.63M | 1.65M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.77M | 9.88M | 8.39M | 7.46M | 7.54M |
| Change in Net Operating Assets | -70.00K | -6.57M | -8.27M | -13.31M | -10.28M |
| Cash from Operations | -60.08M | -62.44M | -64.23M | -62.89M | -59.08M |
| Capital Expenditure | -208.00K | -211.00K | -183.00K | -179.00K | -156.00K |
| Sale of Property, Plant, and Equipment | 70.00K | 70.00K | 55.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -138.00K | -141.00K | -128.00K | -179.00K | -156.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -489.00K | -477.00K | -474.00K | -475.00K | -475.00K |
| Issuance of Common Stock | 186.26M | 187.10M | 187.17M | 276.46M | 98.22M |
| Repurchase of Common Stock | -17.00K | -17.00K | -17.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.40M | -14.18M | -20.08M | 74.52M | 73.97M |
| Cash from Financing | 173.36M | 172.43M | 166.60M | 350.50M | 171.71M |
| Foreign Exchange rate Adjustments | -95.00K | -23.00K | 15.00K | 63.00K | -8.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.04M | 109.83M | 102.26M | 287.50M | 112.47M |